A meta-epidemiological assessment of transparency indicators of infectious disease models.

Emmanuel A Zavalis, John P A Ioannidis
Author Information
  1. Emmanuel A Zavalis: Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, United States of America. ORCID
  2. John P A Ioannidis: Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, California, United States of America. ORCID

Abstract

Mathematical models have become very influential, especially during the COVID-19 pandemic. Data and code sharing are indispensable for reproducing them, protocol registration may be useful sometimes, and declarations of conflicts of interest (COIs) and of funding are quintessential for transparency. Here, we evaluated these features in publications of infectious disease-related models and assessed whether there were differences before and during the COVID-19 pandemic and for COVID-19 models versus models for other diseases. We analysed all PubMed Central open access publications of infectious disease models published in 2019 and 2021 using previously validated text mining algorithms of transparency indicators. We evaluated 1338 articles: 216 from 2019 and 1122 from 2021 (of which 818 were on COVID-19); almost a six-fold increase in publications within the field. 511 (39.2%) were compartmental models, 337 (25.2%) were time series, 279 (20.9%) were spatiotemporal, 186 (13.9%) were agent-based and 25 (1.9%) contained multiple model types. 288 (21.5%) articles shared code, 332 (24.8%) shared data, 6 (0.4%) were registered, and 1197 (89.5%) and 1109 (82.9%) contained COI and funding statements, respectively. There was no major changes in transparency indicators between 2019 and 2021. COVID-19 articles were less likely to have funding statements and more likely to share code. Further validation was performed by manual assessment of 10% of the articles identified by text mining as fulfilling transparency indicators and of 10% of the articles lacking them. Correcting estimates for validation performance, 26.0% of papers shared code and 41.1% shared data. On manual assessment, 5/6 articles identified as registered had indeed been registered. Of articles containing COI and funding statements, 95.8% disclosed no conflict and 11.7% reported no funding. Transparency in infectious disease modelling is relatively low, especially for data and code sharing. This is concerning, considering the nature of this research and the heightened influence it has acquired.

References

  1. J Clin Epidemiol. 2021 Aug;136:96-132 [PMID: 33781862]
  2. JAMA Dermatol. 2017 Dec 1;153(12):1229-1235 [PMID: 29049553]
  3. Pharmacoecon Open. 2017 Jun;1(2):73-77 [PMID: 29442337]
  4. Science. 2020 May 1;368(6490):482-483 [PMID: 32355024]
  5. Front Public Health. 2016 Sep 28;4:213 [PMID: 27734014]
  6. R Soc Open Sci. 2021 Sep 7;8(9):210389 [PMID: 34527271]
  7. Lancet Glob Health. 2020 Dec;8(12):e1459-e1460 [PMID: 33125915]
  8. Pharmacoecon Open. 2020 Mar;4(1):1-4 [PMID: 31975349]
  9. Sci Rep. 2021 Oct 8;11(1):20027 [PMID: 34625589]
  10. Gigascience. 2016 Jul 11;5(1):30 [PMID: 27401684]
  11. PLoS Comput Biol. 2013 Oct;9(10):e1003285 [PMID: 24204232]
  12. Nat Hum Behav. 2018 Jan;2(1):6-10 [PMID: 30980045]
  13. Math Biosci. 2022 Mar;345:108782 [PMID: 35090877]
  14. BMC Med. 2019 Sep 16;17(1):174 [PMID: 31526369]
  15. Epidemics. 2018 Dec;25:1-8 [PMID: 29853411]
  16. Pharmacoeconomics. 2019 Nov;37(11):1305-1312 [PMID: 31347104]
  17. Epidemiol Rev. 2022 Jan 14;43(1):166-175 [PMID: 34505122]
  18. PLoS Comput Biol. 2021 Feb 12;17(2):e1008618 [PMID: 33577550]
  19. Bioinformatics. 2008 Sep 15;24(18):2122-3 [PMID: 18658182]
  20. Pharmacoeconomics. 2019 Nov;37(11):1409-1410 [PMID: 31065916]
  21. J Cheminform. 2020 Jan 28;12(1):9 [PMID: 33430992]
  22. PLoS Biol. 2021 Mar 1;19(3):e3001107 [PMID: 33647013]
  23. Environ Model Softw. 2020 Dec;134:104873 [PMID: 32958993]
  24. Int Stat Rev. 2020 Aug;88(2):462-513 [PMID: 32834402]
  25. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D689-91 [PMID: 16381960]
  26. Science. 2020 Jul 24;369(6502):368-369 [PMID: 32703861]
  27. PLoS One. 2016 Dec 22;11(12):e0168512 [PMID: 28005986]
  28. Parasit Vectors. 2021 Jun 29;14(1):345 [PMID: 34187546]
  29. Sci Data. 2016 Mar 15;3:160018 [PMID: 26978244]
  30. N Engl J Med. 2020 Jul 23;383(4):303-305 [PMID: 32412711]
  31. PLoS One. 2013 Jun 21;8(6):e67111 [PMID: 23805293]
  32. Bull World Health Organ. 1998;76(4):327-33 [PMID: 9803583]
  33. Proc Natl Acad Sci U S A. 2002 May 14;99 Suppl 3:7280-7 [PMID: 12011407]
  34. J Clin Epidemiol. 2008 Apr;61(4):344-9 [PMID: 18313558]
  35. Eur J Pharm Sci. 2017 Nov 15;109S:S65-S71 [PMID: 28684136]
  36. JAMA Otolaryngol Head Neck Surg. 2018 Mar 01;144(3):194-201 [PMID: 29270633]
  37. Science. 2016 Dec 9;354(6317):1240-1241 [PMID: 27940837]
  38. PLoS Comput Biol. 2021 Jul 12;17(7):e1009146 [PMID: 34252083]
  39. PLoS One. 2019 Sep 30;14(9):e0222986 [PMID: 31568489]
  40. J Clin Epidemiol. 2015 Sep;68(9):1046-58 [PMID: 26279400]
  41. Lancet. 2020 Mar 28;395(10229):1036-1037 [PMID: 32197104]
  42. PLoS Comput Biol. 2021 Dec 21;17(12):e1009690 [PMID: 34932560]
  43. Science. 2011 Feb 11;331(6018):649 [PMID: 21310971]
  44. PLoS Biol. 2016 Jan 04;14(1):e1002333 [PMID: 26726926]
  45. Eur J Epidemiol. 2020 Aug;35(8):733-742 [PMID: 32780189]
  46. J Comput Neurosci. 2017 Feb;42(1):1-10 [PMID: 27629590]
  47. Int J Environ Res Public Health. 2019 Nov 06;16(22): [PMID: 31698706]
  48. PLoS Med. 2021 Oct 19;18(10):e1003793 [PMID: 34665805]

MeSH Term

COVID-19
Communicable Diseases
Conflict of Interest
Disclosure
Humans
Pandemics

Word Cloud

Created with Highcharts 10.0.0modelsarticlesCOVID-19codefundingtransparencyinfectiousindicators9%sharedpublicationsdisease20192021dataregisteredstatementsassessmentespeciallypandemicsharingevaluatedtextmining2%25contained5%8%COIlikelyvalidationmanual10%identifiedMathematicalbecomeinfluentialDataindispensablereproducingprotocolregistrationmayusefulsometimesdeclarationsconflictsinterestCOIsquintessentialfeaturesdisease-relatedassessedwhetherdifferencesversusdiseasesanalysedPubMedCentralopenaccesspublishedusingpreviouslyvalidatedalgorithms1338articles:2161122818almostsix-foldincreasewithinfield51139compartmental337timeseries27920spatiotemporal18613agent-based1multiplemodeltypes2882133224604%119789110982respectivelymajorchangeslessshareperformedfulfillinglackingCorrectingestimatesperformance260%papers411%5/6indeedcontaining95disclosedconflict117%reportedTransparencymodellingrelativelylowconcerningconsideringnatureresearchheightenedinfluenceacquiredmeta-epidemiological

Similar Articles

Cited By